David Turkaly
Stock Analyst at JMP Securities
(2.31)
# 2,571
Out of 4,836 analysts
138
Total ratings
42.19%
Success rate
-3.08%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $252.55 | +10.87% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $13.55 | +84.50% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $35.48 | +55.02% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $95.77 | +30.52% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $444.35 | +12.52% | 1 | May 5, 2025 | |
| SYK Stryker | Reiterates: Market Perform | n/a | $394.69 | - | 3 | May 5, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $128.13 | - | 15 | Apr 2, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $12 → $7 | $1.15 | +508.70% | 6 | Mar 21, 2025 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $22.98 | +117.58% | 10 | Mar 21, 2025 | |
| AXGN Axogen | Reiterates: Market Outperform | $26 | $11.76 | +121.09% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $19.45 | +64.52% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $61.05 | - | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $125 → $100 | $69.36 | +44.18% | 11 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.68 | +84.33% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $78.25 | +43.13% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $1.49 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $4.29 | -30.07% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $12.05 | - | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $3.98 | +0.50% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $10.45 | -52.15% | 1 | Oct 6, 2017 |
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $252.55
Upside: +10.87%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $13.55
Upside: +84.50%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $35.48
Upside: +55.02%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $95.77
Upside: +30.52%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $444.35
Upside: +12.52%
Stryker
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $394.69
Upside: -
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $128.13
Upside: -
TELA Bio
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.15
Upside: +508.70%
OrthoPediatrics
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $22.98
Upside: +117.58%
Axogen
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $11.76
Upside: +121.09%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $19.45
Upside: +64.52%
Feb 24, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $61.05
Upside: -
Feb 7, 2025
Maintains: Market Outperform
Price Target: $125 → $100
Current: $69.36
Upside: +44.18%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.68
Upside: +84.33%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $78.25
Upside: +43.13%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $1.49
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $4.29
Upside: -30.07%
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.05
Upside: -
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $3.98
Upside: +0.50%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $10.45
Upside: -52.15%